Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet lysate for rotator cuff tendinopathy
IRCT20160422027520N17Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2020
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet lysate in shoulder tendinopathy, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pain by visual analog scale, Shoulder Pain and Disability Index and 1 more. Started May 2020; status: completed.
02
Drugs
platelet lysate
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on IRCT20160422027520N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160422027520N17.